Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic radical prostatectomy: assessment after 240 procedures.

B Guillonneau1, F Rozet, E Barret

  • 1Department of Urology, Institut Mutualiste Montsouris, Paris, France. bertrand.guillonneau@imm.fr

The Urologic Clinics of North America
|March 30, 2001
PubMed
Summary

Laparoscopic radical prostatectomy offers a safe and effective surgical option for localized prostate cancer. This minimally invasive approach shows low morbidity, reduced pain, and promising oncologic outcomes, potentially improving functional recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erectile dysfunction following prostate biopsy: a comparative analysis of transrectal versus transperineal approaches.

International urology and nephrology·2025
Same author

[Early detection of prostate cancer: Towards a new paradigm?]

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Mid-term oncologic outcomes of radical prostatectomy in lymph node metastatic prostate cancer patients.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Surgical Oncology

Background:

  • Radical prostatectomy is a standard treatment for localized prostate cancer.
  • Conventional open surgery can lead to significant morbidity and functional sequelae.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of transperitoneal laparoscopic radical prostatectomy.
  • To assess the safety, efficacy, and functional results of this minimally invasive approach.

Main Methods:

  • Transperitoneal laparoscopic radical prostatectomy performed by an experienced urologic team.
  • Evaluation of operative and postoperative morbidity, pain, hospital stay, and oncologic results.

Main Results:

  • Successful procedure with low operative and postoperative morbidity.

Related Experiment Videos

  • Minimal postoperative pain, enabling shorter hospital stays.
  • Satisfactory short-term oncologic results and potential for reduced functional sequelae (incontinence, impotence).

    • Conclusions:

    • Laparoscopic radical prostatectomy is a viable and effective treatment for localized prostate cancer.
    • The enhanced visualization in laparoscopy may lead to improved dissection precision.
    • Further studies with longer follow-up are needed to confirm functional outcomes and long-term oncologic control.